Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Insect cells as a factory to produce adeno-associated virus type 2 vectors.

Urabe M, Ding C, Kotin RM.

Hum Gene Ther. 2002 Nov 1;13(16):1935-43.

PMID:
12427305
2.

Large-scale recombinant adeno-associated virus production.

Kotin RM.

Hum Mol Genet. 2011 Apr 15;20(R1):R2-6. doi: 10.1093/hmg/ddr141. Epub 2011 Apr 29. Review.

3.

Strategies for manufacturing recombinant adeno-associated virus vectors for gene therapy applications exploiting baculovirus technology.

Negrete A, Kotin RM.

Brief Funct Genomic Proteomic. 2008 Jul;7(4):303-11. doi: 10.1093/bfgp/eln034. Epub 2008 Jul 16. Review.

4.

Toward exascale production of recombinant adeno-associated virus for gene transfer applications.

Cecchini S, Negrete A, Kotin RM.

Gene Ther. 2008 Jun;15(11):823-30. doi: 10.1038/gt.2008.61. Epub 2008 Apr 10. Review.

PMID:
18401433
5.

Recent advances in recombinant adeno-associated virus vector production.

Clark KR.

Kidney Int. 2002 Jan;61(1 Suppl):S9-15. Review.

6.

Adenovirus-adeno-associated virus hybrid for large-scale recombinant adeno-associated virus production.

Zhang H, Xie J, Xie Q, Wilson JM, Gao G.

Hum Gene Ther. 2009 Sep;20(9):922-9. doi: 10.1089/hum.2009.125. Review.

PMID:
19618999
7.
8.

Production of recombinant adeno-associated virus vectors.

Zolotukhin S.

Hum Gene Ther. 2005 May;16(5):551-7. Review.

PMID:
15916480
9.

Adenovirus and adeno-associated virus vectors.

Lai CM, Lai YK, Rakoczy PE.

DNA Cell Biol. 2002 Dec;21(12):895-913. Review.

PMID:
12573049
10.

Large-scale adeno-associated viral vector production using a herpesvirus-based system enables manufacturing for clinical studies.

Clément N, Knop DR, Byrne BJ.

Hum Gene Ther. 2009 Aug;20(8):796-806. doi: 10.1089/hum.2009.094. Review.

11.

Manufacturing of recombinant adeno-associated viruses using mammalian expression platforms.

Robert MA, Chahal PS, Audy A, Kamen A, Gilbert R, Gaillet B.

Biotechnol J. 2017 Mar;12(3). doi: 10.1002/biot.201600193. Epub 2017 Feb 8. Review.

PMID:
28177193
12.

[Large-scale production of recombinant adeno-associated virus (rAAV)].

Wang F, Diao Y, Xiao W, Xu R.

Sheng Wu Gong Cheng Xue Bao. 2009 Nov;25(11):1608-13. Review. Chinese.

PMID:
20222456
13.

Molecular design for recombinant adeno-associated virus (rAAV) vector production.

Aponte-Ubillus JJ, Barajas D, Peltier J, Bardliving C, Shamlou P, Gold D.

Appl Microbiol Biotechnol. 2018 Feb;102(3):1045-1054. doi: 10.1007/s00253-017-8670-1. Epub 2017 Dec 4. Review.

14.

Manufacturing recombinant adeno-associated viral vectors from producer cell clones.

Thorne BA, Takeya RK, Peluso RW.

Hum Gene Ther. 2009 Jul;20(7):707-14. doi: 10.1089/hum.2009.070. Review.

PMID:
19848592
15.
16.

Progress in adeno-associated virus type 2 vector production: promises and prospects for clinical use.

Grimm D, Kleinschmidt JA.

Hum Gene Ther. 1999 Oct 10;10(15):2445-50. Review.

PMID:
10543610
17.

Pharmacology of Recombinant Adeno-associated Virus Production.

Penaud-Budloo M, François A, Clément N, Ayuso E.

Mol Ther Methods Clin Dev. 2018 Jan 8;8:166-180. doi: 10.1016/j.omtm.2018.01.002. eCollection 2018 Mar 16. Review.

18.

[Chemical modification of recombinant adenovirus-associated virus vectors].

Zhang D, Qiu F, Diao Y.

Bing Du Xue Bao. 2013 Sep;29(5):566-72. Review. Chinese.

PMID:
24386848
19.

Host cells and cell banking.

Stacey GN, Merten OW.

Methods Mol Biol. 2011;737:45-88. doi: 10.1007/978-1-61779-095-9_3. Review.

PMID:
21590393
20.

Manufacturing of recombinant adeno-associated viral vectors for clinical trials.

Clément N, Grieger JC.

Mol Ther Methods Clin Dev. 2016 Mar 16;3:16002. doi: 10.1038/mtm.2016.2. eCollection 2016. Review.

Supplemental Content

Support Center